Ocean Platform Joins apps.health Marketplace to Help Connect Patients with Healthcare Providers
Ocean Platform Joins apps.health Marketplace to Help Connect Patients with Healthcare Providers TORONTO, Sept. 29, 2020 /CNW/ – The Ocean Platform, Canada’s leading EMR-integrated digital health suite for patient engagement, is now available on apps.health, a digital health app marketplace and innovation hub from WELL Health. With this release, CognisantMD is also launching a series of powerful … Continue reading Ocean Platform Joins apps.health Marketplace to Help Connect Patients with Healthcare Providers
COVID-19 has significantly increased the use of many technologies among older Canadians: poll
COVID-19 has significantly increased the use of many technologies among older Canadians: poll TORONTO, Sept. 29, 2020 /CNW/ – From Facebook to food delivery apps and fitness trackers, older Canadians have upped their use of many technologies and online services during the COVID-19 pandemic. A new AGE-WELL poll conducted by Environics Research in July 2020 shows … Continue reading COVID-19 has significantly increased the use of many technologies among older Canadians: poll
Toronto startup, Virdect, pioneers major advance in Covid-19 detection
Toronto startup, Virdect, pioneers major advance in Covid-19 detection New method provides advance warning, precise geotargeting, for huge potential savings in cost and lives TORONTO, Sept. 29, 2020 /CNW/ – Toronto startup Virdect announced today that it is pioneering a new system for detecting Covid-19 that has enormous implications for identifying outbreaks and containing them quickly. Using … Continue reading Toronto startup, Virdect, pioneers major advance in Covid-19 detection
Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia
Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia REBLOZYL® is the first and only erythroid maturation agent approved for use in Canada MONTREAL, Sept. 29, 2020 /CNW/ – Bristol Myers Squibb Canada (BMS) and Acceleron Pharma Inc. announced today that Health Canada has approved REBLOZYL® (luspatercept) for the treatment of … Continue reading Health Canada Approves REBLOZYL® (luspatercept), New Class of Treatment for Adult Patients Living with Beta Thalassemia
Report warns of potential increase in hospital admissions due to lack of dementia supportMental health of people living with dementia adversely affected by lockdown
Report warns of potential increase in hospital admissions due to lack of dementia supportMental health of people living with dementia adversely affected by lockdown 29 September 2020 Dementia support services should be restored to pre-Covid levels to prevent a possible rise in costly hospital admissions, a new study suggests.The findings are published as part of a national … Continue reading Report warns of potential increase in hospital admissions due to lack of dementia supportMental health of people living with dementia adversely affected by lockdown
